Eli Lilly Stock Hits Record High As Diabetes Powerhouse Stokes Beat And Raise - Investor's Business Daily
- Eli Lilly Stock Hits Record High As Diabetes Powerhouse Stokes Beat And Raise Investor's Business Daily
- Lilly hits record high after Mounjaro fuels forecast raise, rival data Reuters
- Eli Lilly raises full-year guidance as Mounjaro, other drugs drive second-quarter profit up 85% CNBC
- Soaring sales of diabetes drug Mounjaro, widely used for weight loss, sends Eli Lilly to new heights AOL
- View Full Coverage on Google News